EDC4 and myeloid sarcoma: In confirmed chronic active lesion borders of MS patients (Figures 4Ai–iii), we observed striking densities of EDC4+ structures (Figure 4A), which appeared much larger than the P-bodies observed in our in vitro studies (Figures 2A,B).